Mitotype Precision Labs Information

Mitotype is a specialist CRO focused on enabling drug discovery. The company is built around a simple belief: a patient’s own cells can tell us more about disease – and how a therapeutic will perform – than standard models alone. Our goal is to accelerate access to effective treatments for patients with currently incurable diseases, with a particular focus on neurodegenerative conditions such as Alzheimer’s and Parkinson’s. We work directly with patient-derived cells, measuring over 100 mitochondrial parameters to reveal the biological detail that generic approaches can miss. This helps distinguish between a therapeutic that just looks promising on paper and one that has a genuine chance of helping the people it is intended for. By identifying promising therapeutic candidates earlier, we aim to reduce late-stage failure. With a clearer picture of how a compound behaves in human biology, our clients can make decisions sooner and with greater confidence, helping promising therapies move towards the clinic. Working with biotechs, pharma, CROs, research organisations and patient advocacy groups, we bring deep, world-leading expertise in mitochondrial biology and drug discovery to every project. Our scientists will help you to understand what your data means and where it should lead next, from designing a study through to interpreting the results.